QUICK LINKS
MAIN MENU
CONNECT WITH US

Clinical Trial Details

Title
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesion (ABSORB III)
Study Purpose
The pivotal trial to support the US pre-market approval (PMA) of Absorb BVS. ABSORB III will evaluate the safety and effectiveness of the Absorb BVS System compared to the XIENCE in the treatment of subjects, including those with diabetes mellitus, with ischemic heart disease caused by up to two de novo native coronary artery lesions in separate epicardial vessels.
Study Plan
Subjects will be randomized to treatment with the study device or an FDA approved stent.
Investigators

Principal Investigator
Theodore A. Bass, M.D.
Medicine

Sub Investigator
Dominick J. Angiolillo, M.D., Ph.D., FACC
Medicine

Sub Investigator
Martin "M" Zenni, M.D.
Medicine

Meeting Schedule & Submission Deadlines

Resources

News & Announcements

Spotlighting innovation and discovery on campus - Thumb

Spotlighting innovation and discovery on campus

5/30/2018

Residents, faculty and staff share their latest research, garner awards during annual Celebration of Research event Nipa Shah, MD, se... [full story]

Aging studies center officially opens  - Thumb

Aging studies center officially opens

5/16/2018

JAX-ASCENT to focus on research targeting adults 60 and older    The clipping of a blue ribbon Friday, May 11, marked t... [full story]

A culturally sensitive approach to weight loss - Thumb

A culturally sensitive approach to weight loss

3/16/2018

Black women participants are sought for a $2.1 million research project targeting obesity UF Health researchers are looking for primar... [full story]

Upcoming Events

There are currently no events to display. Check back soon!